73 related articles for article (PubMed ID: 21899945)
1. The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1.
Benad P; Rauner M; Rachner TD; Hofbauer LC
Cancer Lett; 2011 Dec; 312(1):101-8. PubMed ID: 21899945
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
4. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
6. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
7. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
9. MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).
Fjelldal R; Moe BT; Ørbo A; Sager G
Anticancer Res; 2010 Dec; 30(12):4835-40. PubMed ID: 21187460
[TBL] [Abstract][Full Text] [Related]
10. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
[TBL] [Abstract][Full Text] [Related]
11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
13. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines.
Hevir N; Trošt N; Debeljak N; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):206-16. PubMed ID: 21182832
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668.
Fog CK; Christensen IJ; Lykkesfeldt AE
Breast Cancer Res Treat; 2005 May; 91(2):133-44. PubMed ID: 15868441
[TBL] [Abstract][Full Text] [Related]
16. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
18. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
Akbas SH; Timur M; Ozben T
J Surg Res; 2005 May; 125(1):49-55. PubMed ID: 15836850
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
20. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]